Anders Tuv
Chief Investment Officer bei Radiumhospitalets Forskningsstiftelse
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Anders Tuv
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.
11
| Foundation/Endowment | Financial Conglomerates | 11 |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.
6
| Holding Company | Biotechnology | 6 |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Nucligen AS
1
| Private Company | 1 | |
Artbio AS
Artbio AS BiotechnologyHealth Technology Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni.
1
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anders Tuv
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Oslo | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Birk Venture AS
Birk Venture AS Investment ManagersFinance Birk Venture AS (Birk Venture) is an independent Scandinavian venture capital firm which was founded in 2010 by Hans Ivar Robinson. Based in Oslo, Norway, the firm focuses exclusively on the life science industry, utilizing their industry experience and international network to partner with young companies with significant growth prospects. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Pfizer AS
Pfizer AS Pharmaceuticals: MajorHealth Technology Pfizer AS operates as biopharmaceutical company, which engages in the development and manufacture of pharmaceutical products. It develops and produces medicines such as penicillin; vaccines; and medicines for the treatment of cancer, pain, cardiovascular disease, diabetes, mental illness, and rheumatism. The firm also offers drugs against parasites. The company was founded on November 25, 1959 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ULTIMOVACS ASA | Pharmaceuticals: Major | Chairman Director/Board Member | |
Accession Therapeutics Limited
Accession Therapeutics Limited BiotechnologyHealth Technology Accession Therapeutics Limited is a British biotech company that is developing novel immuno-oncology therapeutics to eradicate cancers by harnessing the immune system more powerfully than ever before. The company is based in Oxford, UK and was founded in 2020 by Bent K. Jakobsen, who has been the CEO since then. The company's product, Trocept, is the first approach that meets the three requirements of being highly specific, broad in action to kill all cancer cell variants present, and potent in activating the full immune system arsenal local to the tumour. The team is built around successful biotech entrepreneurs experienced in taking projects through to the clinic and is supported by a Board comprising experienced international healthcare investors. | Biotechnology | Founder Director/Board Member | |
BI Norwegian Business School | College/University | Undergraduate Degree Graduate Degree | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Sales & Marketing | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Troms Kraft AS
Troms Kraft AS Alternative Power GenerationUtilities Troms Kraft AS produces, distributes, and sells electricity. It owns and operates power line networks, hydropower plants, and wind farms. The company was founded in 1898 and is headquartered in Tomasjord, Norway. | Alternative Power Generation | Director/Board Member | |
Stiftinga Det Norske Samlaget | Chairman | ||
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Georgetown University | College/University | Graduate Degree | |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Hospital/Nursing Management | Chief Executive Officer | |
Invitrogen Dynal AS | Corporate Officer/Principal | ||
NEL ASA | Industrial Machinery | Director/Board Member | |
Giamag Technologies AS
Giamag Technologies AS Industrial MachineryProducer Manufacturing GIAMAG Technologies AS specializes in product development for life science applications using their proprietary magnet technology. The company was founded in 2012 by Arne Torbjørn Skjeltorp and is based in Kjeller, Norway. The Norwegian company has ongoing projects with industrial partners and hospitals, partly financed by the Research Council of Norway, Innovation Norway, and project partners. In addition to product development, they also provide industry partners with magnet simulations, prototyping, and quality testing. GIAMAG has extensive experience in running R&D projects and a broad network within the research environment. The CEO is Tone Blixøen. | Industrial Machinery | Director/Board Member | |
Regionalt Forskningsfond Innlandet | Corporate Officer/Principal | ||
Noregs forskingsråd | General Government | Director/Board Member | |
NMBU Realtek | Director/Board Member | ||
Institute For Energy Technology
Institute For Energy Technology Miscellaneous Commercial ServicesCommercial Services Institute For Energy Technology (IFE) is a research organization based in Kjeller, Norway. The Norwegian company has been internationally leading since 1948 and have contributed to new renewable energy solutions, petroleum technology, and industry. IFE stands for the Department of Energy Technology, and they bridge the gap between research, education, and industrial activities. The private company's research focuses on energy and materials for a better future. The company has subsidiaries in Tistedalsgata and Os, Norway. | Miscellaneous Commercial Services | President | |
Oslo universitetssykehus HF
Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
HAFSLUND ASA | Electric Utilities | Director/Board Member | |
Lovisenberg Diakonale Sykehus AS
Lovisenberg Diakonale Sykehus AS Hospital/Nursing ManagementHealth Services Lovisenberg Diakonale Sykehus AS provides internal medical services. It offers mental health care, interdisciplinary specialized drug treatments, planned surgical activities, as well as oral medical treatments. The company was founded on December 9, 1992 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Chairman | |
Helse Sør-Øst RHF
Helse Sør-Øst RHF Hospital/Nursing ManagementHealth Services Helse Sør-Øst RHF owns healthcare companies and hospitals. It provides specialized health services. The company was founded in 2007 and is headquartered in Hamar, Norway. | Hospital/Nursing Management | Chairman | |
Norwegian Institute of Technology | College/University | Graduate Degree | |
Norges Skiforbund
Norges Skiforbund Movies/EntertainmentConsumer Services Norges Skiforbund organizes sports teams and clubs. The firm prepares skiing activity and develops top athletes. It provides combined jumping and cross country skiing, alpine skiing, freestyle, and driving. The company was founded in 1908 and is headquartered in Oslo, Norway. | Movies/Entertainment | Director/Board Member | |
PHOTOCURE ASA | Medical Specialties | Chairman | |
Farmastat AS | Chairman | ||
Advokatfirmaet Hjort DA
Advokatfirmaet Hjort DA Miscellaneous Commercial ServicesCommercial Services Advokatfirmaet Hjort DA provides legal services. Its areas of competence includes transport and tax law; property law; protection of privacy; marketing and intellectual property law; and human rights. The firm offers range of legal services to corporate clients in the public and private sectors, as well as private individuals. The company was founded by Harald Nørregaard in 1893 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Reykjavik University | College/University | Doctorate Degree | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Founder | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Founder | |
The Institute of Molecular Medicine | Corporate Officer/Principal | ||
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Founder | |
Engimmune Therapeutics AG
Engimmune Therapeutics AG Packaged SoftwareTechnology Services Engimmune Therapeutics AG is a developer of off-the-shelf soluble T-cell receptor drugs to treat solid tumors. The company is based in Allschwil, Switzerland. The Swiss company's proprietary platform technologies enable them to engineer stable, multi-specific TCRs that have high affinity for target cancer antigens and trigger a potent and durable anti-cancer T-cell response without causing damage to healthy cells. The company was founded in 2021 as a spin-off of ETH Zurich from technologies developed by Dr. Rodrigo Vazquez-Lombardi and Professor Sai Reddy. Lars Nieba has been the CEO of the company since 2023. | Packaged Software | Chairman | |
University of Bielefeld | College/University | Doctorate Degree | |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Biotechnology | Director/Board Member | |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Norwegen | 30 |
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 5 |
Dänemark | 3 |
Schweden | 3 |
Sektoral
Health Technology | 18 |
Consumer Services | 9 |
Commercial Services | 9 |
Health Services | 5 |
Utilities | 3 |
Operativ
Director/Board Member | 41 |
Corporate Officer/Principal | 26 |
Chairman | 15 |
Chief Executive Officer | 14 |
Founder | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Anders Tuv
- Unternehmensverbindungen